Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01689220
What this trial is testing

SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Who this might be right for
Peripheral T-cell Lymphoma
Solasia Pharma K.K. 6
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00322842
What this trial is testing

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 35
Testing effectiveness (Phase 2)UnknownNCT02983942
What this trial is testing

Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Beijing Tiantan Hospital 50
Not applicableUnknownNCT03234140
What this trial is testing

Constitutional Genetics in Follicular Lymphoma

Who this might be right for
Follicular LymphomaGenetic Predisposition to Disease
Hospices Civils de Lyon 1,883
Testing effectiveness (Phase 2)UnknownNCT04615468
What this trial is testing

TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Who this might be right for
Peripheral T-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Not applicableStudy completedNCT01533168
What this trial is testing

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 12
Testing effectiveness (Phase 2)UnknownNCT00927797
What this trial is testing

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Who this might be right for
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Heidelberg University 185
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Large-scale testing (Phase 3)UnknownNCT03745261
What this trial is testing

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Henan University of Traditional Chinese Medicine 240
Testing effectiveness (Phase 2)Ended earlyNCT01914718
What this trial is testing

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 26
Not applicableEnded earlyNCT04947618
What this trial is testing

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

Who this might be right for
Lymphoma, Malignant
Centre Hospitalier Universitaire de Nīmes 136
Not applicableStudy completedNCT05203523
What this trial is testing

Investigational Dementia Treatment Study

Who this might be right for
Dementia, Mild
University of Manitoba 73
Large-scale testing (Phase 3)UnknownNCT05351346
What this trial is testing

Genotype-guided Treatment in DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 1,100
Testing effectiveness (Phase 2)UnknownNCT01593488
What this trial is testing

Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic Leukemia
National Cancer Institute, Naples 31
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT00265018
What this trial is testing

HD10 for Early Stages

Who this might be right for
Hodgkin´s Lymphoma
University of Cologne 1,370
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT02332980
What this trial is testing

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more
Mayo Clinic 65
Early research (Phase 1)WithdrawnNCT07428486
What this trial is testing

FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase IFLAG ChemotherapyLisaftoclax+3 more
M.D. Anderson Cancer Center
Next Page